TC
IMMU

TFS Capital’s Immunomedics Inc IMMU Stock Holding History

TFS Capital’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-40,836
Closed -$70K – 994
2015
Q3 		$70K Buy
+40,836
New +$104K 0.01% 827
2015
Q2 		– Sell
-43,865
Closed -$168K – 1166
2015
Q1 		$168K Sell
43,865
-738,594
-94% -$3.21M 0.02% 808
2014
Q4 		$3.76M Buy
782,459
+590,084
+307% +$2.33M 0.36% 43
2014
Q3 		$716K Buy
192,375
+28,950
+18% +$97.9K 0.06% 482
2014
Q2 		$597K Buy
+163,425
New +$600K 0.05% 578

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TFS Capital's IMMU Position: Q4 2015 in Review

TFS Capital sold out of Immunomedics Inc (IMMU) in Q4 2015, closing a stake of 40,836 shares — an estimated $70K sold.

TFS Capital first reported a position in IMMU in Q2 2014 and held it in 5 quarters. The position peaked at $3.76M in Q4 2014. 92 funds tracked by Wall St. Rank hold IMMU as of Q4 2015.

  • TFS Capital reported no remaining Immunomedics Inc position as of Q4 2015 after selling out during the quarter.
  • TFS Capital sold 40,836 Immunomedics Inc shares in Q4 2015, an estimated $70K.
  • TFS Capital first reported a position in Immunomedics Inc in Q2 2014 and held it in 5 quarters.
  • TFS Capital's Immunomedics Inc position peaked at $3.76M in Q4 2014.
  • 92 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2015.

Based on TFS Capital's 13F filing for Q4 2015, filed 29 Jan 2016.